Melatonin overcomes gemcitabine resistance in pancreatic ductal adenocarcinoma by abrogating nuclear factor-κB activation.
about
What is known about melatonin, chemotherapy and altered gene expression in breast cancerEffects of Melatonin and Its Analogues on Pancreatic Inflammation, Enzyme Secretion, and Tumorigenesis.Melatonin enhances sensitivity to fluorouracil in oesophageal squamous cell carcinoma through inhibition of Erk and Akt pathwayMelatonin synergizes the chemotherapeutic effect of 5-fluorouracil in colon cancer by suppressing PI3K/AKT and NF-κB/iNOS signaling pathways.Melatonin promotes circadian rhythm-induced proliferation through Clock/histone deacetylase 3/c-Myc interaction in mouse adipose tissue.Disrupting G6PD-mediated Redox homeostasis enhances chemosensitivity in colorectal cancer.Lactacystin-Induced Model of Hypertension in Rats: Effects of Melatonin and Captopril.Melatonin-induced increase in sensitivity of human hepatocellular carcinoma cells to sorafenib is associated with reactive oxygen species production and mitophagy.Melatonin and Hippo Pathway: Is There Existing Cross-Talk?Gemcitabine-induced heparanase promotes aggressiveness of pancreatic cancer cells via activating EGFR signaling.Melatonin increases the effect of 5-fluorouracil-based chemotherapy in human colorectal adenocarcinoma cells in vitro.Inhibiting MT2-TFE3-dependent autophagy enhances melatonin-induced apoptosis in tongue squamous cell carcinoma.FOXO1: Another avenue for treating digestive malignancy?Mst1 regulates colorectal cancer stress response via inhibiting Bnip3-related mitophagy by activation of JNK/p53 pathway.Everolimus Inhibits Growth of Gemcitabine-Resistant Pancreatic Cancer Cells via Induction of Caspase-Dependent Apoptosis and G2 /M Arrest.Melatonin suppresses thyroid cancer growth and overcomes radioresistance via inhibition of p65 phosphorylation and induction of ROS.
P2860
Q33597963-1CAD2973-D387-4B88-BB13-2042ECCCA004Q33755141-978F7838-DD6C-4E3C-925D-923DEF5EEC77Q37465949-51092226-487A-41C0-83E8-9ABCB8D72877Q38730168-90BDDDD8-B429-443F-9073-CD2AD0FEE8C8Q39092878-E261D56A-52F2-4C1E-9EA3-5DA3E839135CQ40129598-B42638F2-94A0-4F6C-8EB3-EC60C5E9A118Q41572967-729F4C30-1BCB-40D9-BD4A-2FC2A64B5F8BQ41651606-27729F03-9DFA-4DF3-910D-C8FFE302F9ECQ41660894-79C13917-2E20-406F-8462-B38E799E5E83Q41709484-5DF32F5C-E7E0-4CF7-8923-52D9E6EB987BQ46319469-B7DD526D-A2EB-4551-AEFE-134D4CB70C6AQ47578133-B42AED39-0E7D-45D9-A289-E839D0D02464Q47613328-1C952861-2E97-400B-AE55-A0C6569CD63EQ47731644-2F15F089-2362-41DD-8F62-389220E11BBDQ48273650-75C91D7A-559E-4814-BA72-17C477D3B71CQ54258517-09F764FD-2D60-4929-AFF4-29B28370E2FA
P2860
Melatonin overcomes gemcitabine resistance in pancreatic ductal adenocarcinoma by abrogating nuclear factor-κB activation.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Melatonin overcomes gemcitabin ...... nuclear factor-κB activation.
@en
type
label
Melatonin overcomes gemcitabin ...... nuclear factor-κB activation.
@en
prefLabel
Melatonin overcomes gemcitabin ...... nuclear factor-κB activation.
@en
P2093
P2860
P356
P1476
Melatonin overcomes gemcitabin ...... g nuclear factor-κB activation
@en
P2093
Jun-Bo Zeng
Le-Zong Chen
Paul J Chiao
Wuguo Deng
Yun-Xin Lu
P2860
P356
10.1111/JPI.12285
P577
2015-10-17T00:00:00Z